Frequently bought together

Brand : XIBAX

XIBAX 90/MG TAB 28/TAB

Sku : I-026503
Key features
Xibax 90mg Film-Coated Tablet 28 Tabl is a film-coated tablet containing etoricoxib 90 mg. It acts as a selective cyclooxygenase‑2 (COX‑2) inhibitor, reducing prostaglandin synthesis that mediates pain and inflammation with relatively less COX‑1 inhibition than nonselective NSAIDs. It is indicated for the symptomatic treatment of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and acute gouty arthritis. Supplied as a prescription-only film-coated tablet in packs of 28.
- Brand: XIBAX
- Active Ingredient: Etoricoxib 90mg
- Strength: 90mg
- Dosage Form: Film-coated tablet
- Pack Size: 28 Tablets
- Route: Oral use
- Prescription Status: Prescription
- Therapeutic Class: Analgesic
- Pharmacological Group: COX-2 Inhibitors
- Drug Class: Selective COX-2 Inhibitor (Coxib) NSAID
- Manufacturer: (Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd
- Country of Origin: Saudi Arabia
- SFDA Registration No.: 1510246047
- Shelf Life: 36 months
- Storage: store below 30°c
- Pain Type: Joint/Muscular
- Nsaid: Yes
- Opioid: No

Frequently bought together

Description

Specification

Indications

Approved Uses

Symptomatic treatment of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute gouty arthritis.

Side Effects

Common Side Effects

Headache, dizziness, dyspepsia/indigestion, abdominal pain, nausea, diarrhea, peripheral edema, increased blood pressure, fatigue/weakness, flu‑like symptoms.

Pharmacology

Mechanism of Action

Selective cyclooxygenase‑2 (COX‑2) inhibition, reducing prostaglandin synthesis mediating pain, inflammation (and fever), with relatively less COX‑1 inhibition than nonselective NSAIDs.